Multidrug-resistant tuberculosis

Multidrug-resistant tuberculosis

Show other versions (2)

Despite the efforts made worldwide to reduce the number of cases of drug-susceptible tuberculosis, multidrug-resistant tuberculosis (MDR-TB) constitutes an important public health issue. Around 440,000 new cases of MDR-TB are estimated annually, although in 2008 only 7% of these (29,423 cases) were...

Full description

Bibliographic Details
Main Authors:	Antônio Carlos Moreira Lemos, Eliana Dias Matos
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Multidrug-resistant tuberculosis Review Diagnosis Treatment
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000200018&lng=en&tlng=en

Similar Items

Multidrug-resistant tuberculosis
by: Antônio Carlos Moreira Lemos, et al.
Published: (2013-04-01)

Diagnosis and treatment of multidrug-resistant tuberculosis
by: Jong Geol Jang, et al.
Published: (2020-10-01)

Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China
by: Yi Hu, et al.
Published: (2016-01-01)

Multidrug-resistant tuberculosis in children and response to therapy
by: Ira Shah
Published: (2015-01-01)

Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study
by: Ye Minn Htun, et al.
Published: (2018-11-01)

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen
by: Maham Farshidpour, et al.
Published: (2013-01-01)

Laboratory cost analysis of conventional and newer molecular tests for diagnosis of presumptive multidrug-resistant tuberculosis patients
by: Raj Narayan Yadav, et al.
Published: (2022-01-01)

Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt
by: Mohsen A. Gadallah, et al.
Published: (2016-11-01)

Multidrug-resistant tuberculosis
by: Álvarez-Gaviria Manuel, et al.
Published: (2013-06-01)

Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment
by: Rupak Singla, et al.
Published: (2018-01-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Scrofula Caused by Multidrug-Resistant Tuberculosis
by: Bárbara Pedro, et al.
Published: (2020-01-01)

A breakthrough in the treatment of multidrug-resistant tuberculosis: A novel and effective approach
by: Vaishali Pardeshi, et al.
Published: (2022-01-01)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
by: Shereen Katrak, et al.
Published: (2021-05-01)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
by: Julia Ershova, et al.
Published: (2015-11-01)

Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China
by: Temesgen Yihunie Akalu, et al.
Published: (2024-02-01)

Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience
by: Alena Skrahina, et al.
Published: (2016-01-01)

Underreported Threat of Multidrug-Resistant Tuberculosis in Africa
by: Yanis Ben Amor, et al.
Published: (2008-09-01)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
by: Jay Achar, et al.
Published: (2015-11-01)

Review on Bovine Tuberculosis: An Emerging Disease Associated with Multidrug-Resistant <i>Mycobacterium</i> Species
by: Mohamed Borham, et al.
Published: (2022-06-01)

Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis.
by: Ángela Tobón, et al.
Published: (2020-12-01)

Multidrug resistant tuberculosis treatment outcome in children in developing and developed countries: A systematic review and meta-analysis
by: Habteyes Hailu Tola, et al.
Published: (2020-07-01)

Hepatitis Associated With Prothionamide for Treatment of Multidrug-resistant Tuberculosis
by: Han-Lin Hsu, et al.
Published: (2010-12-01)

Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone
by: Harriet N. A. Blankson, et al.
Published: (2024-03-01)

A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country
by: Hasnain Javed, et al.
Published: (2016-01-01)

Correlation between the BACTEC MGIT 960 culture system with Genotype MTBDRplus and TB-SPRINT in multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil
by: Nayanne Gama Teixeira Dantas, et al.

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control
by: Ajoy Kumar Verma, et al.
Published: (2022-05-01)

Prediction of treatment outcomes for multidrug-resistant tuberculosis by whole-genome sequencing
by: Guiqing He, et al.
Published: (2020-07-01)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
by: Russell R. Kempker, et al.
Published: (2015-06-01)

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework
by: Pablos-Méndez Ariel, et al.
Published: (2002-01-01)

Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China
by: Kefyalew Addis Alene, et al.
Published: (2017-08-01)

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013
by: Ying Peng, et al.
Published: (2017-01-01)

Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study
by: Belachew T, et al.
Published: (2022-06-01)

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Hossein Hatami, et al.
Published: (2022-05-01)

Comparison of short term and long term multidrug resistant tuberculosis treatment outcomes in tertiary care settings
by: Muhammad Kashif Munir, et al.
Published: (2024-04-01)

TREATMENT OUTCOMES OF MULTIDRUG RESISTANT TUBERCULOSIS PATIENTS IN EAST JAVA FROM 2014 TO 2017
by: Lailatul Fitriya, et al.
Published: (2020-05-01)

Surveillance of multidrug-resistant tuberculosis in Taiwan, 2008–2019
by: Mei-Hua Wu, et al.
Published: (2023-02-01)

Associated factors with the development of multidrug resistant pulmonary tuberculosis in the department of Piura, Peru 2009-2014
by: Susy Bazan-Ruiz
Published: (2019-01-01)

Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead
by: Greta Musteikienė, et al.
Published: (2016-01-01)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
by: Elisabeth Sanchez-Padilla, et al.
Published: (2012-01-01)